{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T14:37:22Z","timestamp":1794407842013,"version":"4.9.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,6,18]],"date-time":"2018-06-18T00:00:00Z","timestamp":1529280000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008322","name":"CSL Behring","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13054-018-2086-x","type":"journal-article","created":{"date-parts":[[2018,6,18]],"date-time":"2018-06-18T11:55:00Z","timestamp":1529322900000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":100,"title":["Early fibrinogen concentrate therapy for major haemorrhage in trauma (E-FIT 1): results from a UK multi-centre, randomised, double blind, placebo-controlled pilot trial"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3849-0688","authenticated-orcid":false,"given":"Nicola","family":"Curry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Foley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henna","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Mora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elinor","family":"Curnow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agne","family":"Zarankaite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renate","family":"Hodge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Hopkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Deary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Ray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phil","family":"Moss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Reed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Kellett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross","family":"Davenport","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Stanworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,18]]},"reference":[{"key":"2086_CR1","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1097\/SLA.0000000000000837","volume":"261","author":"SA Tisherman","year":"2015","unstructured":"Tisherman SA, Schmicker RH, Brasel KJ, Bulger EM, Kerby JD, et al. Detailed description of all deaths in both the shock and traumatic brain injury hypertonic saline trials of the resuscitation outcomes consortium. Ann Surg. 2015;261:586\u201390.","journal-title":"Ann Surg"},{"key":"2086_CR2","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1097\/ALN.0000000000001428","volume":"126","author":"R Davenport","year":"2017","unstructured":"Davenport R, Guerreiro M, Frith D, Rourke C, Platton S, et al. Activated protein C drives the hyperfibrinolysis of acute traumatic coagulopathy. Anaesthesiology. 2017;126:115\u201327.","journal-title":"Anaesthesiology"},{"key":"2086_CR3","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1111\/jth.12078","volume":"11","author":"I Raza","year":"2013","unstructured":"Raza I, Davenport R, Rourke C, Platton S, Manson J, et al. The incidence and magnitude of fibrinolytic activation in trauma patients. J Thromb Haemost. 2013;11:307\u201314.","journal-title":"J Thromb Haemost"},{"key":"2086_CR4","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1111\/j.1538-7836.2012.04752.x","volume":"10","author":"C Rourke","year":"2012","unstructured":"Rourke C, Curry N, Khan S, Taylor R, Raza I, et al. Fibrinogen levels during trauma hemorrhage, response to replacement therapy, and association with patient outcomes. J Thromb Haemost. 2012;10:1342\u201351.","journal-title":"J Thromb Haemost"},{"key":"2086_CR5","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1016\/j.injury.2016.11.021","volume":"48","author":"ZK McQuilten","year":"2017","unstructured":"McQuilten ZK, Wood EM, Bailey M, Cameron PA, Cooper DJ. Fibrinogen is an independent predictor of mortality in major trauma patients: a five-year statewide cohort study. Injury. 2017;48:1074\u201381.","journal-title":"Injury"},{"key":"2086_CR6","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1097\/TA.0000000000000146","volume":"76","author":"S Khan","year":"2014","unstructured":"Khan S, Brohi K, Chana M, Raza I, Stanworth S, et al. Hemostatic resuscitation is neither hemostatic nor resuscitative in trauma hemorrhage. J Trauma Acute Care Surg. 2014;76:561\u20137.","journal-title":"J Trauma Acute Care Surg"},{"key":"2086_CR7","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/voxs.12376","volume":"13","author":"H Wong","year":"2017","unstructured":"Wong H, Curry N. Do we need cryoprecipitate in the era of fibrinogen concentrate and other specific factor options? Vox Sang. 2017;13:23\u20138. \n                    https:\/\/doi.org\/10.1111\/voxs.12376\n                    \n                  .","journal-title":"Vox Sang"},{"key":"2086_CR8","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1111\/aas.12734","volume":"60","author":"NHL Jensen","year":"2016","unstructured":"Jensen NHL, Stensballe J, Afshari A. Comparing efficacy and safety of fibrinogen concentrate to cryoprecipitate in bleeding patients: a systematic review. Acta Anaesthesiol Scand. 2016;60:1033\u201342. \n                    https:\/\/doi.org\/10.1111\/aas.12734\n                    \n                  .","journal-title":"Acta Anaesthesiol Scand"},{"key":"2086_CR9","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1093\/bja\/aev134","volume":"115","author":"N Curry","year":"2015","unstructured":"Curry N, Rourke C, Davenport R, Beer S, Pankhurst L, et al. Early cryoprecipitate for major haemorrhage in trauma: a randomised controlled feasibility trial. Br J Anaesth. 2015;115:76\u201383.","journal-title":"Br J Anaesth"},{"key":"2086_CR10","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1093\/bja\/aew343","volume":"117","author":"B Nascimento","year":"2016","unstructured":"Nascimento B, Callum J, Tien H, Peng H, Rizoli S, et al. Fibrinogen in the initial resuscitation of severe trauma (FiiRST): a randomized feasibility trial. Br J Anaesth. 2016;117:775\u201382.","journal-title":"Br J Anaesth"},{"key":"2086_CR11","unstructured":"Joint United Kingdom (UK) Blood Transfusion and Tissue Transplantation Services Professional Advisory Committee. Red book: guidelines for the blood transfusion services in the UK. 8th ed. \n                    https:\/\/www.transfusionguidelines.org\/red-book\n                    \n                  . Accessed 14 Apr 2018."},{"key":"2086_CR12","doi-asserted-by":"publisher","first-page":"R52","DOI":"10.1186\/cc13798","volume":"18","author":"JS Hagemo","year":"2014","unstructured":"Hagemo JS, Stanworth SJ, Juffermans NP, Brohi K, Cohen M, et al. Prevalence, predictors and outcome of hypofibrinogenaemia in trauma: a multicenter observational study. Crit Care. 2014;18:R52.","journal-title":"Crit Care"},{"key":"2086_CR13","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1111\/j.1538-7836.2009.03331.x","volume":"7","author":"C Fenger-Eriksen","year":"2009","unstructured":"Fenger-Eriksen C, Jensen TM, Kristensen BS, Jensen KM, T\u00f8nnesen E, et al. Fibrinogen substitution improves whole blood clot firmness in bleeding patients undergoing radical cystectomy: a randomized, placebo-controlled clinical trial. J Thromb Haemost. 2009;7:795\u2013802.","journal-title":"J Thromb Haemost"},{"key":"2086_CR14","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jemermed.2015.09.017","volume":"50","author":"D Bruynseels","year":"2016","unstructured":"Bruynseels D, Solomon C, Hallam CPW, Collis RE, et al. Commentary on reconstituting fibrinogen concentrate to maintain blinding in a double-blind, randomized trial in an emergency setting. J Emerg Med. 2016;50:104\u20137.","journal-title":"J Emerg Med"},{"key":"2086_CR15","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1093\/bja\/aex181","volume":"119","author":"PW Collins","year":"2017","unstructured":"Collins PW, Cannings-John R, Bruynseels D, Mallaiah S, Dick J, et al. Viscoelastometric-guided early fibrinogen concentrate replacement during postpartum haemorrhage: OBS2, a double-blind randomized controlled trial. Br J Anaesth. 2017;119:411\u201321.","journal-title":"Br J Anaesth"},{"key":"2086_CR16","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1111\/bjh.13580","volume":"170","author":"BJ Hunt","year":"2015","unstructured":"Hunt BJ, Allard S, Keeling D, Norfolk D, Stanworth SJ, et al. British Committee for Standards in Haematology. A practical guideline for the haematological management of major haemorrhage. Br J Haematol. 2015;170:788\u2013803.","journal-title":"Br J Haematol"},{"key":"2086_CR17","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/S0140-6736(07)60411-5","volume":"369","author":"S Nadel","year":"2007","unstructured":"Nadel S, Goldstein B, Williams MD, Dalton H, Peters M, et al. Drotrecogin alfa (activated) in children with severe sepsis: a multicentre phase III randomised controlled trial. Lancet. 2007;369:836\u201343.","journal-title":"Lancet"},{"key":"2086_CR18","unstructured":"EQ-5D-5L user guide: basic information on how to use the EQ-5D-5L instrument. Version 2.1. April 2015. \n                    https:\/\/euroqol.org\/wp-content\/uploads\/2016\/09\/EQ-5D-5L_UserGuide_2015.pdf\n                    \n                  . Accessed 18 Oct 2017."},{"key":"2086_CR19","doi-asserted-by":"publisher","first-page":"663","DOI":"10.7326\/0003-4819-134-8-200104170-00012","volume":"134","author":"DG Altman","year":"2001","unstructured":"Altman DG, Schulz KF, Moher D, CONSORT Group. The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med. 2001;134:663\u201394.","journal-title":"Ann Intern Med"},{"key":"2086_CR20","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.jss.2014.01.055","volume":"190","author":"JV Karri","year":"2014","unstructured":"Karri JV, Cardenas JC, Johansson PI, Matijevic N, Cotton BA, Wade CE, Holcomb JB. In vitro efficacy of RiaSTAP after rapid reconstitution. J Surg Res. 2014;190:655\u201361. \n                    https:\/\/doi.org\/10.1016\/j.jss.2014.01.055\n                    \n                  .","journal-title":"J Surg Res"},{"key":"2086_CR21","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13049-015-0165-4","volume":"23","author":"M Ponschab","year":"2015","unstructured":"Ponschab M, Voelckel W, Pavelka M, Schlimp CJ, Schochl H. Effect of coagulation factor concentrate administration on ROTEM\u00ae parameters in major trauma. Scand J Trauma Resusc Emerg Med. 2015;23:84.","journal-title":"Scand J Trauma Resusc Emerg Med"},{"key":"2086_CR22","doi-asserted-by":"publisher","first-page":"e258","DOI":"10.1016\/S2352-3026(17)30077-7","volume":"4","author":"P Innerhofer","year":"2017","unstructured":"Innerhofer P, Fries D, Mittermayr M, Innerhofer N, von Langen D, et al. Reversal of trauma-induced coagulopathy using first-line coagulation factor concentrates or fresh frozen plasma (RETIC): a single-Centre, parallel-group, open-label, randomised trial. Lancet Haematol. 2017;4:e258\u201371.","journal-title":"Lancet Haematol"},{"key":"2086_CR23","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1111\/trf.14550","volume":"58","author":"PM Lochandwala","year":"2018","unstructured":"Lochandwala PM, O\u2019Neal A, Patel EU, Brunker PAR, Gehrie EA, et al. Hemostatic profile and safety of pooled cryoprecipitate up to 120 hours after thawing. Transfusion. 2018;58:1126\u201331.","journal-title":"Transfusion"},{"key":"2086_CR24","doi-asserted-by":"publisher","first-page":"R55","DOI":"10.1186\/cc8948","volume":"14","author":"H Sch\u00f6chl","year":"2010","unstructured":"Sch\u00f6chl H, Nienaber U, Hofer G, Voelckel W, Jambor C, et al. Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrate. Crit Care. 2010;14:R55.","journal-title":"Crit Care"},{"key":"2086_CR25","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1097\/SLA.0000000000001608","volume":"263","author":"E Gonzalez","year":"2016","unstructured":"Gonzalez E, Moore EE, Moore HB, Chapman MP, Chin TL, et al. Goal-directed hemostatic resuscitation of trauma-induced coagulopathy: a pragmatic randomized clinical trial comparing a viscoelastic assay to conventional coagulation assays. Ann Surg. 2016;263:1051\u20139.","journal-title":"Ann Surg"},{"key":"2086_CR26","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1111\/anae.13920","volume":"72","author":"P Stein","year":"2017","unstructured":"Stein P, Kaserer A, Sprengel K, Wanner GA, Seifert B, et al. Change of transfusion and treatment paradigm in major trauma patients. Anaesthesia. 2017;72:1317\u201326.","journal-title":"Anaesthesia"},{"key":"2086_CR27","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1001\/jama.2015.12","volume":"313","author":"JB Holcomb","year":"2015","unstructured":"Holcomb JB, Tilley BC, Baraniuk S, Fox EE, Wade CE, et al. Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial. JAMA. 2015;313:471\u201382.","journal-title":"JAMA"},{"key":"2086_CR28","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s13054-016-1265-x","volume":"20","author":"R Rossaint","year":"2016","unstructured":"Rossaint R, Bouillon B, Cerny V, Coats TJ, Duranteau J, et al. The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition. Crit Care. 2016;20:100.","journal-title":"Crit Care"},{"key":"2086_CR29","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1016\/S0140-6736(11)60278-X","volume":"377","author":"CRASH-2 trial collaborators","year":"2011","unstructured":"CRASH-2 trial collaborators. The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet. 2011;377:1096\u2013101.","journal-title":"Lancet"},{"key":"2086_CR30","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1001\/2013.jamasurg.387","volume":"148","author":"JB Holcomb","year":"2013","unstructured":"Holcomb JB, del Junco DJ, Fox EE, Wade CE, Cohen MJ, et al. The prospective, observational, multicenter, major trauma transfusion (PROMMTT) study: comparative effectiveness of a time-varying treatment with competing risks. JAMA Surg. 2013;148:127\u201336.","journal-title":"JAMA Surg"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-018-2086-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13054-018-2086-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-018-2086-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,17]],"date-time":"2019-06-17T19:30:08Z","timestamp":1560799808000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-018-2086-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,18]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["2086"],"URL":"https:\/\/doi.org\/10.1186\/s13054-018-2086-x","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,18]]},"assertion":[{"value":"13 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"An emergency waiver with an independent agreement process was used. The protocol and consent process were approved by the NRES Committee South Central Oxford C (15\/S3\/0316) and the MHRA (25224\/0003\/001-0001). Written informed consent was sought from the participant as soon as practically possible after study entry for continuation in the trial. If the participant did not regain capacity, agreement was sought from the participant\u2019s next of kin or other appropriate representative.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"NC has received support for conference attendance from CSL Behring and is a consultant for LFB. RD has received consultancy fees from LFB. All other authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"164"}}